Now more than ever, I see a window of opportunity to combat chronic health issues via the tactical utilization of technological advances including, but not limited to, Conversational AI, machine learning, high-performance computing, cloud-based platforms, IoT integrations, EHRs and others.
AI bridges the complexity of intractable medical problems
Only machine learning provides us with the opportunity to both ingest various disparate data sources and make relevant sense of the issue at stake when dealing with multi-factorial diseases.
Can Conversational AI solve the obesity crisis?
Conversational cognitive assistants can engage, educate and support people through their health plan to improve adherence and help them achieve the best results.
Solving the obesity epidemic: Is Artificial Intelligence the answer?
Artificial intelligence may hold the key to solving the obesity epidemic and relieving pressure on healthcare services.
Tech companies respond to the opioid crisis whilst pharma executives face criminal charges
A combination of virtual conversational agents, machine learning, and deep learning technologies could assist the clinical community in combating the opioid epidemic.
Chatbots vs. cognitive AI in healthcare
Chatbots and Conversational AI systems are not the same. Nowhere is the distinction more important than in the healthcare industry.
AI’s role in addressing treatment regimens for low back pain
Worldwide, low back pain is the single greatest cause of disability. Cognitive AI solutions such as the Amelia platform could help provide a measure of relief.
The chronic pain epidemic and the role of AI
Advances in Artificial Intelligence and related technologies are opening up new possibilities for addressing how chronic pain management can be made more effective.
From taking GP appointments by video or voice call to developing screening solutions to spot patients with indicators of the virus at home, a whole host of different solutions have been designed and deployed by tech firms and other start-up businesses repurposing their products to help support overwhelmed healthcare organizations in the fight against COVID-19.
How COVID-19 is driving AI adoption across the healthcare industry
Looking to the future to a post-COVID-19 world, within the next few years I expect that both patients and doctors will become more accustomed to interacting with online services and, increasingly, Conversational AI-powered assistants.
Pandemic possibilities: healthcare reform amid COVID-19
Cognitive agents have been deployed so that whether sheltered-in-place or quarantined at home, any member of the general public is able to reach an AI-powered cognitive assistant by voice call or a browser to receive an assessment of risk, as well as additional information about the pandemic.
Elderly care in a post-pandemic world
An aging population has brought an array of age-related diseases – including arthritis, hypertension, diabetes, cancer, dementia, COPD and many others – for healthcare providers to grapple with. These challenges have worsened in light of the COVID-19 pandemic.
There seems to be broad consensus among medical professionals that AI presents both opportunities and risks that need to be addressed prior to its widespread integration into the healthcare delivery ecosystem.
Artificial consent: should doctors be telling patients more about AI?
The use of AI is becoming increasingly prevalent in hospitals, helping practitioners to make informed decisions about patient care.
AiThority Interview with Dr. S. Vincent Grasso, Global Practice Leader at Amelia, an IPsoft Company
Unlike chatbots, Conversational AI assistants can understand the intent of statements, so people can speak as they would with a human.
The tech of health: How wearable technology is the key to long-term fitness
There is significant concern over the privacy and security implications of patient private health information being captured and transmitted by an ever-growing number of vendors. Patients have very little insight, if any, into what is happening to their private health information that is being captured and transmitted by clinical apps.
Despite the hardships and limitations imposed by the current COVID-19 Pandemic, Dr. Grasso is delivering value within three concurrent roles: Healthcare & Life Sciences Global Practice Lead for Amelia, an IPsoft Company, the world’s leading private AI company; Chief Technology Officer for a rapidly expanding network of Federally Qualified Health Centers (FQHCs) servicing Chicago's Southland; and a practicing physician within a multispecialty clinic in Newark, NJ.
Follow him on LinkedIn.
Dr. Grasso leverages his subject matter expertise (SME) within the domains of healthcare and life sciences, technology, and business to optimize value contribution, market differentiation, and competitive advantage within the global marketplace.
His diverse subject matter expertise (clinical/business/IT) was forged during the past 20 years within multiple senior leadership positions in both public and private organizations. These roles included Chief Executive Officer, Chief Medical Officer, Chief Medical Information Officer, Program Manager, and other related roles. Organization types included medical device manufacturers, global technology consulting practices, Fortune 100 companies, healthcare delivery organizations, and healthcare IT startups.
Unlike the vast majority of physicians that posses only clinical experience, or clinical experience with 1 other non clinical graduate degree, Dr. Grasso possesses graduate level distinction in 2 non clinical domains. His educational experiences includes an MBA in Finance and Business Process Reengineering from the University of Massachusetts Amherst; a Master of Science in Information Systems from New Jersey Institute of Technology, a Doctorate of Osteopathic Medicine and Surgery from Des Moines University, a Fellowship in Medical Informatics from NASA Yale University Commercial Space Center for Medical Informatics and Technology Applications (CSCMITA), a Fellowship in Advanced Minimally Invasive Surgery from Yale University School of Medicine, a General Surgery Residency from Mount Sinai School of Medicine, an Internal Medicine Internship from Robert Wood Johnson School of Medicine, Year Abroad in Dante Studies & Culinary Arts at the University of Bologna, and a BA in Fine Arts/Chemistry from St. Peter's University.
In addition, he has been heavily involved in Agile software development methodologies since its inception and holds active certifications as a Certified Scrum Master (CSM) and Project Manager (PMP). Dr. Grasso has been active in global humanitarian relief efforts via his not for profit AYUDAMOS and has received Governmental Recognition of Humanitarian Service from Bolivia, Cambodia, Guatemala, Haiti, Nepal, Peru, Serbia, and Uganda.
Follow Dr. Grasso on LinkedIn.